ACR: App Helps Manage Fibromyalgia Through Acceptance and Commitment Therapy
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 21, 2023 -- A smartphone-based acceptance and commitment therapy (ACT) app may help patients manage fibromyalgia (FM), according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 10 to 15 in San Diego.
Michael Gendreau, M.D., from Gendreau Consulting in Poway, California, and colleagues evaluated the effectiveness of the smartphone-based, prescription digital app FM-ACT. The analysis included 275 individuals meeting 2016 FM diagnostic criteria who were randomly assigned to receive either 12 weeks of FM-ACT or a digital symptom tracker control (ST); all patients remained on any ongoing FM treatment(s).
The researchers found that at week 12, 70.6 percent of the FM-ACT participants reported an improvement on the Patient Global Impression of Change, which was significantly greater than that reported by ST participants (22.2 percent). FM-ACT exposure was significantly associated with a greater posttreatment reduction on the Revised Fibromyalgia Impact Questionnaire total score versus the ST arm (effect size, 0.65). Additionally, FM-ACT was statistically superior to the control treatment for pain intensity and interference, PROMIS Fatigue and Sleep Disturbance, Beck Depression Inventory II, Psychological Inflexibility in Pain Scale, and committed action. There were no treatment-related adverse events reported.
"Validated digital ACT therapy provided by FM-ACT, combined with the low-risk safety profile of this device-based intervention, offers an important step forward in reaching and benefiting the broader FM population with a nondrug therapy," the authors write.
Several authors disclosed financial ties to Swing Therapeutics, the developer of the FM-ACT app.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
American College of Rheumatology, Nov. 10-15
The annual meeting of the American College of Rheumatology was held this year from Nov. 10 to 15 in San Diego, and attendees included rheumatology specialists, physicians...
Cognitive-Behavioral Therapy Helps Relieve Fibromyalgia Pain
FRIDAY, Sept. 22, 2023 -- Cognitive-behavioral therapy (CBT) is superior to a matched education treatment in reducing the interfering effects of pain and other aspects of...
Review IDs Certain Higher Mortality Risks for Patients With Fibromyalgia
FRIDAY, July 14, 2023 -- Patients with fibromyalgia have an increased risk for mortality, particularly from infections and suicide; however, they appear to have a lower risk for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.